Analysis of 02211.HK (Grand Health International) Making It to Hong Kong Stock Market Hot List
Unlock More Features
Login to access AI-powered analysis, deep research reports and more advanced features

About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
Related Stocks
The event occurred at 10:30:02 on December 22, 2025 (UTC+8), when 02211.HK (Grand Health International) appeared on the Hong Kong Stock Market Surge List of the East Money App.
02211.HK belongs to the healthcare sector, but data retrieval faces significant challenges: no real-time or historical prices, trading volume, or other transaction data have been obtained, nor are there recent company announcements or news updates [0]. The only traceable information is that Sohu Finance mentioned the stock’s price-to-earnings ratio at the time was 5.92 times when comparing pharmaceutical companies on July 7, 2025 [1], and the basic listing information of the stock on East Money Website [2].
- Insufficient liquidity may be the core cause: No transaction data indicates that the stock may have extremely low liquidity; a small trading volume can trigger large price fluctuations, thus making it to the surge list [0].
- Speculative trading driven by retail investors: As a mainstream retail investor platform in China, the East Money App’s hot list effect may attract short-term speculative funds, driving abnormal stock price movements [2].
- Main Risks:
- Lack of information transparency: No public financial or operational data to evaluate the company’s fundamentals [0];
- Liquidity risk: Low liquidity may lead to trading difficulties and extreme price fluctuations [0];
- Speculative risk: Speculative trading triggered by the hot list effect lacks fundamental support, making price trends unsustainable [2].
- Opportunities: Due to the extreme scarcity of data, no clear investment opportunities have been identified yet.
02211.HK made it to the Hong Kong Stock Market Surge List on the East Money App, but the lack of data casts doubt on the reasons for its rise. Investors need to fully recognize the risks of information transparency, liquidity, and speculative trading faced by this stock, and carefully evaluate the possibility of investment.
Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.
About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
